|


There are relatively few reasons why an individual might not qualify for
a Sonocur® treatment but the following will disqualify a potential patient
from treatment:
Listed below are contraindications for treatment including information on contraindicated prescriptions and a review of the importance of localized, palpable pain. Please take a moment to review this important information.
Contraindications
-
Poorly localized or non palpable area of pain.
-
No
recent X-ray, CT
scan or MRI of the area
-
Pregnancy
-
A bleeding disorder
such as hemophilia or an acquired bleeding disorder
-
Blood dyscrasia
or other disorder with platelet count less than 50,000
-
An open wound
over the site to be treated
-
Redness, swelling,
fever, or other evidence of infection or acute inflammation at the
site to be treated
-
Uncooperative
patient or one who cannot follow directions (Alzheimer's disease,
senile dementia, organic brain syndrome, etc.)
Prescriptions and Allergies
-
Patients should
take their regular medications during their series of treatments.
-
Patients on Coumadin
(Wafarin) or other anti-coagulants should not be treated.
-
Patients may continue
taking aspirin or other non-steroidal anti-inflammatory agents
during their series of treatment.
-
Latex hypersensitivity
is not a contraindication to therapy.
Important
In addition to imaging studies, all patients selected
for Sonocur® therapy should have palpable, localized, areas of pain.
If these criteria are not met, the treatment should not be done. Although
the best results of treatment are in patients with a single, palpable
painful site, up to three areas of localized pain at a single site may be
treated at one treatment session (e.g. shoulder). It cannot be
overstated how important this selection criteria is. Patients with
diffuse, non-localized pain should not be treated. If a patient is
referred with a non-localized pain, he or she should be returned to the
referring physician with the appropriate "Extracorporeal Shockwave Therapy Exclusion Form".
The Sonocur® Orthopedic Extracorporeal Shockwave system is available in Canada and other countries where regulatory approval has been obtained. The Sonocur® Basic is FDA approved in the United States for the treatment of chronic lateral epicondylitis (tennis elbow).
© 2012 Sonorex. All rights reserved. By using this service, you accept the terms of our Visitor Agreement. Please read it. The material sonorex.ca is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.
|
|